Hiroshi Kagamu
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 64
- Lung Cancer Research Studies 30
- CAR-T cell therapy research 13
- Immunology top 5%
- Immunotherapy and Immune Responses 28
- Immune Cell Function and Interaction 17
-
- Lung Cancer Treatments and Mutations 61
- Lung Cancer Diagnosis and Treatment 28
- Cancer Research top 10%
- Physiology top 10%
- Asthma and respiratory diseases 17
- Co-authors
- Kyoichi KairaHirohisa YoshizawaIchiei NaritaJunta TanakaOu YamaguchiHiroshi TanakaKunihiko KobayashiAyako Shiono
- Journals
- Allergology International (7 papers)The Journal of Immunology (6 papers)Scientific Reports (5 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroshi Kagamu
166 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 116
- Oncology 1.6k
- Immunology 884
- Pulmonary and Respiratory Medicine 1.0k
- Cancer Research 213
- Physiology 296
Countries citing papers authored by Hiroshi Kagamu
This map shows the geographic impact of Hiroshi Kagamu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kagamu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kagamu more than expected).
Fields of papers citing papers by Hiroshi Kagamu
This network shows the impact of papers produced by Hiroshi Kagamu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kagamu. The network helps show where Hiroshi Kagamu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroshi Kagamu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 16 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 27 | |
| 10 | 2021 | 11 | |
| 11 | 2020 | 13 | |
| 12 | 2019 | 169 | |
| 13 | 2019 | 7 | |
| 14 | 2016 | 43 | |
| 15 | 2014 | 11 | |
| 16 | 2012 | 15 | |
| 17 | 2012 | 22 | |
| 18 | 2008 | 3 | |
| 19 | 2005 | 83 | |
| 20 | 2001 | 26 |
About Hiroshi Kagamu
Hiroshi Kagamu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 172 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (64 papers), Lung Cancer Treatments and Mutations (61 papers), Lung Cancer Research Studies (30 papers), Immunotherapy and Immune Responses (28 papers), Lung Cancer Diagnosis and Treatment (28 papers), Immune Cell Function and Interaction (17 papers), Asthma and respiratory diseases (17 papers) and CAR-T cell therapy research (13 papers). The work is most often cited by research in Oncology (1.6k citations), Immunology (884 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Hiroshi Kagamu has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kyoichi Kaira, Hirohisa Yoshizawa, Ichiei Narita, Junta Tanaka, Ou Yamaguchi, Hiroshi Tanaka, Kunihiko Kobayashi, Ayako Shiono, Yu Miura and Atsuto Mouri. Their work appears in journals such as Allergology International, The Journal of Immunology, Scientific Reports, Cancers and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.